These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Modulating the immune response in demyelinating diseases. Hughes R J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148. PubMed ID: 9489519 [No Abstract] [Full Text] [Related]
10. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Dyck PJ; Litchy WJ; Kratz KM; Suarez GA; Low PA; Pineda AA; Windebank AJ; Karnes JL; O'Brien PC Ann Neurol; 1994 Dec; 36(6):838-45. PubMed ID: 7998769 [TBL] [Abstract][Full Text] [Related]
11. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. Vermeulen M; van Schaik IN; Brand A J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433 [No Abstract] [Full Text] [Related]
12. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Choudhary PP; Hughes RA QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875 [TBL] [Abstract][Full Text] [Related]
13. A practical approach to the use of intravenous immunoglobulin in neurological disease. Wills AJ; Unsworth DJ Eur Neurol; 1998; 39(1):3-8. PubMed ID: 9476717 [TBL] [Abstract][Full Text] [Related]
14. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)]. Saito Y; Yokota T Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607 [TBL] [Abstract][Full Text] [Related]
16. Improvement of neurologic function in chronic inflammatory demyelinating polyradiculoneuropathy following intravenous gamma-globulin infusion. Albala M; McNamara ME; Sokol M; Wyshock E Arch Neurol; 1987 Mar; 44(3):248-9. PubMed ID: 2435270 [No Abstract] [Full Text] [Related]
19. Lichenoid/Interface cutaneous eruptions to IVIg with the primary infusion may be related to the re-regulation of anti-idiotype network. Smith KJ; Dutka AL; Skelton HG J Cutan Med Surg; 1998 Oct; 3(2):96-101. PubMed ID: 9822784 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions. Hamdalla HH; Hawkes CH; Spokes EG; Bamford JM; Goulding PJ BMJ; 1996 Nov; 313(7069):1399-400. PubMed ID: 8956719 [No Abstract] [Full Text] [Related] [Next] [New Search]